Drugs / PA-MSHA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01380808 | May 2011 → Jul 2013 | breast cancer | Fudan University | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PA-MSHA | “Pseudomonas aeruginosa-mannose-sensitive hemagglutinin (PA-MSHA) has been established to have anti-proliferative effects against breast cancer cells in preclinical experiments,...” PMID 25768439 ↗ Mar 2015 |
| Known as | Pseudomonas aeruginosa-mannose-sensitive hemagglutinin | “Pseudomonas aeruginosa-mannose-sensitive hemagglutinin (PA-MSHA) has been established to have anti-proliferative effects against breast cancer cells in preclinical experiments,...” PMID 25768439 ↗ Mar 2015 |
| Route | Subcutaneous | “PA-MSHA 1 mg was administered subcutaneously every other day” PMID 25768439 ↗ Mar 2015 |